• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物信息学分析对转移性和非转移性骨肉瘤样本之间基因差异的鉴定。

Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.

作者信息

Sun Baoyong, Wang Fangxin, Li Min, Yang Mingshan

机构信息

Department of Bone and Soft Tissue Tumor, Shandong Cancer Hospital and Institute, Ji Yan Road No. 440, Jinan, 250117, China,

出版信息

Med Oncol. 2015 May;32(5):153. doi: 10.1007/s12032-015-0604-0. Epub 2015 Apr 2.

DOI:10.1007/s12032-015-0604-0
PMID:25832865
Abstract

To investigate the differences in gene expression level between metastatic and non-metastatic osteosarcoma (OS) samples and the potential mechanism. Gene expression profile data GSE9508 were downloaded from Gene Expression Omnibus database to identify the differentially expressed genes (DEGs) between metastatic, non-metastatic OS samples, and normal control samples via SAM method. Function expression matrix of the DEGs was constructed by calculating the functional node scores based on the genes sets collected from the pathways recorded in MsigDB database. Next, t test was applied to screen the differentially expressed functional nodes between each two kinds of samples. Finally, we compared the significant genes between selected DEGs and genes in differentially expressed functional nodes. There were 79 up-regulated DEGs between non-metastatic OS and normal samples, 380 up-regulated and 134 down-regulated DEGs between the metastatic OS and normal samples, and 761 up-regulated plus 186 down-regulated DEGs between metastatic and non-metastatic OS samples. A total of 3846 functional gene sets were collected to form the function expression profile matrix. The numbers of differentially expressed functional nodes between non-metastatic OS and normal samples, metastatic OS and normal samples, and metastatic and non-metastatic OS samples were 8, 39, and 5, respectively. The gene level difference between metastatic and non-metastatic OS samples can be distinguished using bioinformatics analysis. TGFB1, LFT3, KDM1A, and KRAS genes have the potential to be used as biomarkers for OS; however, further analysis is needed to verify the current results.

摘要

研究转移性与非转移性骨肉瘤(OS)样本之间基因表达水平的差异及其潜在机制。从基因表达综合数据库下载基因表达谱数据GSE9508,通过SAM方法鉴定转移性、非转移性OS样本与正常对照样本之间的差异表达基因(DEGs)。基于从MsigDB数据库记录的通路中收集的基因集计算功能节点得分,构建DEGs的功能表达矩阵。接下来,应用t检验筛选每两种样本之间差异表达的功能节点。最后,比较所选DEGs与差异表达功能节点中的基因之间的显著基因。非转移性OS与正常样本之间有79个上调的DEGs,转移性OS与正常样本之间有380个上调和134个下调的DEGs,转移性与非转移性OS样本之间有761个上调加186个下调的DEGs。共收集3846个功能基因集以形成功能表达谱矩阵。非转移性OS与正常样本、转移性OS与正常样本以及转移性与非转移性OS样本之间差异表达的功能节点数量分别为8、39和5。使用生物信息学分析可以区分转移性与非转移性OS样本之间的基因水平差异。TGFB1、LFT3、KDM1A和KRAS基因有潜力用作OS的生物标志物;然而,需要进一步分析来验证当前结果。

相似文献

1
Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.基于生物信息学分析对转移性和非转移性骨肉瘤样本之间基因差异的鉴定。
Med Oncol. 2015 May;32(5):153. doi: 10.1007/s12032-015-0604-0. Epub 2015 Apr 2.
2
Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.骨肉瘤转移特征相关差异表达通路的生物信息学分析
Int J Mol Med. 2016 Aug;38(2):466-74. doi: 10.3892/ijmm.2016.2657. Epub 2016 Jun 27.
3
Regulatory network of differentially expressed genes in metastatic osteosarcoma.转移性骨肉瘤中差异表达基因的调控网络
Mol Med Rep. 2015 Mar;11(3):2104-10. doi: 10.3892/mmr.2014.3009. Epub 2014 Nov 27.
4
Screening for metastatic osteosarcoma biomarkers with a DNA microarray.用DNA微阵列筛选转移性骨肉瘤生物标志物
Asian Pac J Cancer Prev. 2014;15(4):1817-22. doi: 10.7314/apjcp.2014.15.4.1817.
5
Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells.骨肉瘤 U2OS 细胞静止和衰老时 AURKA/PLK4 的差异表达。
Cell Cycle. 2020 Apr;19(8):884-894. doi: 10.1080/15384101.2020.1731054. Epub 2020 Mar 21.
6
Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.利用RNA测序技术鉴定骨肉瘤发展过程中的差异表达基因。
Oncotarget. 2016 Dec 27;7(52):87194-87205. doi: 10.18632/oncotarget.13554.
7
A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.一种支持向量机分类器,可高精度预测骨肉瘤转移。
Int J Mol Med. 2017 Nov;40(5):1357-1364. doi: 10.3892/ijmm.2017.3126. Epub 2017 Sep 7.
8
Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.与转移性骨肉瘤相关的差异表达基因的鉴定及功能分析
Asian Pac J Cancer Prev. 2014;15(24):10797-801. doi: 10.7314/apjcp.2014.15.24.10797.
9
Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods.基于生物信息学方法鉴定与骨肉瘤转移和预后相关的枢纽基因并构建预后模型。
Medicine (Baltimore). 2024 Jun 7;103(23):e38470. doi: 10.1097/MD.0000000000038470.
10
Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.环状 RNA hsa_circ_0032462、hsa_circ_0028173、hsa_circ_0005909 被预测通过作为 miRNA 海绵在人骨肉瘤中发挥作用来促进 CADM1 的表达。
PLoS One. 2018 Aug 28;13(8):e0202896. doi: 10.1371/journal.pone.0202896. eCollection 2018.

引用本文的文献

1
KRAS regulates IL-17 signal activity by affect the metastasis of osteosarcoma via an IL-17A-dependent manner.KRAS通过依赖白细胞介素-17A的方式影响骨肉瘤转移,从而调节白细胞介素-17信号活性。
JBMR Plus. 2025 Apr 7;9(7):ziaf056. doi: 10.1093/jbmrpl/ziaf056. eCollection 2025 Jul.
2
Identification of potential crucial genes and key pathways in osteosarcoma.鉴定骨肉瘤中的潜在关键基因和关键途径。
Hereditas. 2020 Jul 14;157(1):29. doi: 10.1186/s41065-020-00142-0.
3
miR‑193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma.

本文引用的文献

1
Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.异戊烯半胱氨酸羧甲基转移酶缺乏通过 Notch 抑制加剧 KRAS 驱动的胰腺肿瘤发生。
J Clin Invest. 2013 Nov;123(11):4681-94. doi: 10.1172/JCI65764.
2
Effect of normalization on statistical and biological interpretation of gene expression profiles.标准化对基因表达谱的统计和生物学解释的影响。
Front Genet. 2013 May 31;3:160. doi: 10.3389/fgene.2012.00160. eCollection 2012.
3
Towards mechanism classifiers: expression-anchored Gene Ontology signature predicts clinical outcome in lung adenocarcinoma patients.
miR-193b 与 MYC 相互作用,并抑制骨肉瘤的生长和转移。
Oncol Rep. 2020 Jul;44(1):139-155. doi: 10.3892/or.2020.7601. Epub 2020 Apr 29.
迈向机制分类器:基于表达的基因本体特征预测肺腺癌患者的临床结局
AMIA Annu Symp Proc. 2012;2012:1040-9. Epub 2012 Nov 3.
4
Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.转化生长因子 β1 信号对于骨肉瘤中癌细胞向癌症干细胞的去分化至关重要。
Stem Cells. 2013 Mar;31(3):433-46. doi: 10.1002/stem.1298.
5
Young age at diagnosis, male sex, and decreased lean mass are risk factors of osteoporosis in long-term survivors of osteosarcoma.诊断时年龄较小、男性性别以及瘦体重降低是骨肉瘤长期幸存者骨质疏松的危险因素。
J Pediatr Hematol Oncol. 2013 Jan;35(1):54-60. doi: 10.1097/MPH.0b013e318275193b.
6
Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines.Flt3 激酶的异位表达抑制不同人癌细胞系的增殖并促进细胞死亡。
Cell Biol Toxicol. 2012 Aug;28(4):201-12. doi: 10.1007/s10565-012-9216-z. Epub 2012 Mar 16.
7
Single sample expression-anchored mechanisms predict survival in head and neck cancer.单样本表达锚定机制预测头颈部癌症的生存情况。
PLoS Comput Biol. 2012 Jan;8(1):e1002350. doi: 10.1371/journal.pcbi.1002350. Epub 2012 Jan 26.
8
Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.赖氨酸特异性去甲基化酶 1(LSD1/KDM1A/AOF2/BHC110)在软骨肉瘤、尤文肉瘤、骨肉瘤和横纹肌肉瘤中表达,并作为表观遗传学药物靶点。
Hum Pathol. 2012 Aug;43(8):1300-7. doi: 10.1016/j.humpath.2011.10.010. Epub 2012 Jan 13.
9
Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.三氧化二砷通过靶向 p38(MAPK)和 c-Jun N-末端激酶抑制尤文肉瘤细胞的侵袭性。
Anticancer Drugs. 2012 Jan;23(1):108-18. doi: 10.1097/CAD.0b013e32834bfd68.
10
Missing value imputation for gene expression data: computational techniques to recover missing data from available information.基因表达数据的缺失值填补:从现有信息中恢复缺失数据的计算技术。
Brief Bioinform. 2011 Sep;12(5):498-513. doi: 10.1093/bib/bbq080. Epub 2010 Dec 14.